CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,500 enrolled
Drug / intervention
routine medical careother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03222024
NCT03222024N/ACompleted

Clinical Features, Management and Outcomes of Severe Ischaemic Stroke in Tertiary Hospitals in China: a Multi-centre Prospective Observational Study

West China Hospital·observational·Posted Jul 19, 2017·Updated Oct 28, 2020

In Brief

An observational study evaluating routine medical care for Severe Ischaemic Stroke and Malignant Ischaemic Stroke. Completed, enrolled 2,500 participants across 1 site.

Detailed Summary

This is a multi-centre, prospective cohort study. The aim of this study is to investigate causes, risk factors, clinical course, management and outcomes of severe ischaemic stroke in a real-world setting in tertiary hospitals in China. Patients with acute ischaemic stroke from nine tertiary hospitals in western China will be recruited. Participants will be visited within 24 hours after admission, on day 3, day 7 and at discharge, to collect their clinical data, blood biomarkers, and brain imaging. A structured telephone interview will be conducted for each participant at 3 months and 1 year after stroke onset, respectively, to collect their functional outcomes. In-hospital outcomes include haemorrhagic transformation, brain oedema and death, 3-month and 1-year outcomes include survival status (death or survival) and functional outcome (scores of modified Rankin scale, mRS).

Study Details

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 19, 2017
Enrollment StartSep 12, 2017
Primary CompletionDec 31, 2019
Study CompletionAug 31, 2020
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 9.0 years ago

Interventions

routine medical careother

This is an observational study for clinical course and outcomes of severe ischaemic stroke; therefore, interventions are prescribed by responsible doctors based on patients' clinical conditions, which is not interfered by current study